J.J. Sacco
机构：University of Liverpool, Clatterbridge Cancer Centre NHS Foundation Trust
发表论文 5 篇 · 总被引 14 次 · h-index 2
代表论文
- LBA46 Primary efficacy, safety, and survival data from the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE clinical trial with RP1 combined with nivolumab (2024 · Annals of Oncology · 被引 9)
- 827P An open-label, multicenter, phase I study of RP2 as a single agent and in combination with nivolumab in patients with solid tumors: Safety, efficacy, and biomarker results (2022 · Annals of Oncology · 被引 3)
- 66O Association of a blood T cell fitness gene signature with clinical benefit from ImmTAC bispecific T cell engagers (2024 · Annals of Oncology · 被引 2)
- 1644P Efficacy and safety of RP1 plus nivolumab in patients with advanced anti–PD-1-failed acral melanoma (2025 · Annals of Oncology)
- Primary analysis of the registration-intended cohort of patients with anti–PD-1–failed melanoma from the IGNYTE trial of RP1 plus nivolumab, including clinical subgroup and initial biomarker data (2025 · EJC Skin Cancer)